Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intramuscular bromopride vs metoclopramide vs ondansetron for vomiting in children with suspected gastroenteritis
RBR-5ky3ksPhase 4Completed
- Sponsor
- União Brasileira de Educação e Assistência
- Start
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in noninfective gastroenteritis and colitis comparing Bromopride intramuscular, Metoclopramide intramuscular and Ondansetron intramuscular (3 arms). Primary endpoints: Cessation of vomiting after treatment and Tolerance of oral water challenge. Started Aug 2013; status: completed.
02
Drugs
bromopridemetoclopramideondansetron
03
Conditions
noninfective gastroenteritis and colitis
Beyond the preview
Go deeper on RBR-5ky3ks.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-5ky3ks.